

Cover Story
Conversation with The Cancer LetterFree
Julie R. Gralow, an expert in breast cancer, clinical trials and global health, was named chief medical officer of the American Society of Clinical Oncology.
In Brief


Clinical Roundup


Drugs & Targets


Trending Stories
- Trump executive order to “Make America Healthy Again” cites questionable data from Wuhan
White House cites paper in pay-to-play journal claiming that U.S. has highest age-standardized incidence rate of cancer - FDA grants Cytotron Breakthrough Device Designation for breast, liver and pancreatic cancers
- Fired NCI employee says Trump’s purge was baseless yet punitive
“I feel like I’ve been erased” - As cancer research is threatened, we must engage in political advocacy
- “The Agency finds you are not fit…”
HHS notifications of firing add insult to injury - Pushing for tax cuts, Trump threatens the federal workforce, Medicaid, and cancer research